Chasing Wellness: Gilead’s Remdesivir & Tools for Healthy Isolation

Chasing Wellness: Gilead’s Remdesivir & Tools for Healthy Isolation

  • Af
  • Episode
      178
  • Published
      29. apr. 2020
  • Forlag
0 Anmeldelser
0
Episode
178 of 1787
Længde
26M
Sprog
Engelsk
Format
Kategori
Økonomi & Business

A new study from the NIAID revealed that at least 50% of Covid-19 patients treated with a 5-day dosage of Gilead’s Remdesivir reported improved symptoms and were discharged from the hospital within two weeks. Former FDA Commissioner Dr. Scott Gottlieb describes the treatment as “part of a better toolbox” for fighting the coronavirus, but “not a home run.” Plus, Mindy Grossman, CEO of WW International, (formerly known as Weight Watchers) discusses keeping her business and our bodies well during quarantine.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for Chasing Wellness: Gilead’s Remdesivir & Tools for Healthy Isolation

Other podcasts you might like ...